Dyne Therapeutics, Inc. DYN
18.07 USD +0.71 (+4.09%)
At closeNov 6, 2026, 4:01 PM EST
18.07 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
17.40 Day range 18.33
14.25 52-week range 26.78
- YTD
- -7.62%
- 1 year
- -0.71%
News
benzinga.com Dyne Therapeutics Q3 EPS $(1.06) Misses $(0.92) Estimate Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.92) by 15.22 percent. This is a 39.47 percent decrease over losses of…
globenewswire.com Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights - Biologics License Application (BLA) for z-rostudirsen in exon 51 Duchenne muscular dystrophy (DMD) under priority review by FDA; PDUFA target action date of January 21, 2027 -
benzinga.com Amdocs Posts Downbeat Q4 Earnings, Joins Skyworks Solutions, Tesla And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session U.S. stock futures rose, while Amdocs plunged 39% after missing Q4 estimates and issuing weak FY27 guidance; several other stocks also fell premarket.
benzinga.com Why Limbach Holdings Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket Limbach surged 14.7% after beating Q3 estimates and raising FY26 sales guidance; Curis gained 69.5%, while Cenntro plunged 46.5%.
benzinga.com Oppenheimer Downgrades Dyne Therapeutics to Perform, Lowers Price Target to $15 Oppenheimer analyst Kostas Biliouris downgrades Dyne Therapeutics (NASDAQ:DYN) from Outperform to Perform and lowers the price target from $40 to $15.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…